Company Filing History:
1 out of 24 
1 out of 12 
1 out of 11 Years Active: 2011-2019
Title: The Innovative Contributions of Chang Yell Shin
Introduction
Chang Yell Shin, a prominent inventor based in Seoul, South Korea, has made significant strides in the field of pharmaceuticals with a focus on diabetes and obesity treatment. With a total of three patents to his name, Shin continues to contribute to the advancement of medical science through innovative solutions.
Latest Patents
Chang Yell Shin's latest inventions include a couple of groundbreaking patents. The first patent, titled "Substituted Piperidines Having GPR119 Agonistic Activity," relates to substituted piperidines represented by Chemical Formula 1, known for their GPR119 agonistic activity. This invention also incorporates a comprehensive method for its preparation and a pharmaceutical composition that utilizes this compound.
The second patent focuses on a "Pharmaceutical Composition for Prevention and Treatment of Diabetes or Obesity." This innovative formulation comprises a compound that inhibits the activity of dipeptidyl peptidase-IV (DPP-IV) and may include additional antidiabetic or antiobesity agents. This pharmaceutical composition showcases remarkable glucose tolerance properties and aims to effectively manage blood glucose levels while reducing fat mass in patients, proving beneficial in both diabetes and obesity prevention and treatment.
Career Highlights
Throughout his career, Chang Yell Shin has been associated with notable companies such as Dong-A Pharm Co., Ltd. and Dong-A Pharmaceutical Co., Ltd. His work has positioned him as a key contributor within the pharmaceutical industry, particularly in developing effective treatments for metabolic disorders.
Collaborations
Shin has collaborated with accomplished individuals in his field, including Heung Jae Kim and Woo Young Kwak. These collaborations have enhanced the research and development process, fostering an environment that encourages innovative solutions and advancements in medical therapy.
Conclusion
Chang Yell Shin's contributions to pharmaceutical innovation through his patents underscore his commitment to combatting diabetes and obesity. By developing groundbreaking compounds and compositions, he paves the way for advancements in the treatment of these prevalent health issues. His work continues to inspire others in the field of medical research and innovation.